BC Platforms struck a deal to integrate OmicsBank’s datasets—covering over 12 million patients in India and 500,000 in the UAE—into its BC Unify platform, expanding access to genomic, imaging and clinical biospecimen data for precision medicine research. The partnership promises federated analytics and broader population diversity for drug discovery and regulatory evidence generation. Separately, PharosAI will use 10x Genomics’ Xenium spatial platform to assemble multimodal cancer datasets from UK NHS archived samples, supported by government funding. The effort will pair spatial biology with AI models and make datasets available to researchers, aiming to accelerate biomarker discovery and target validation. These deals signal increased industry investment in large, linked multimodal datasets to power AI-driven diagnostics and therapeutic discovery. Data governance, privacy safeguards, and harmonized metadata will determine the scientific and regulatory value of these integrated resources.